Showing results (21-30 of 214) with videos related to
Sort By:
Pageof 22
Physiological Reviews|March 15, 2018
The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent AngiogenesisLucia Negri, Napoleone FerraraCancer Journal (Sudbury, Mass.)|November 23, 2007
Antiangiogenic therapy for cancer: an updateFarbod Shojaei, Napoleone FerraraThe Journal of Experimental Medicine|January 27, 2022
Vascular heterogeneity: VEGF receptors make blood vessels specialPin Li, Napoleone FerraraNature Biotechnology|July 12, 2012
Modeling and predicting clinical efficacy for drugs targeting the tumor milieuMallika Singh, Napoleone FerraraCell and Tissue Research|September 4, 2008
VEGF inhibition: insights from preclinical and clinical studiesYongping Crawford, Napoleone FerraraFrontiers in Immunology|March 8, 2021
Iron Metabolism in the Tumor Microenvironment: Contributions of Innate Immune CellsWei Liang, Napoleone FerraraMethods in Enzymology|November 22, 2008
Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitorsYongping Crawford, Napoleone FerraraClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Vascular endothelial growth factor signaling pathways: therapeutic perspectiveMarcin Kowanetz, Napoleone FerraraTrends in Pharmacological Sciences|October 20, 2009
Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapiesYongping Crawford, Napoleone FerraraTrends in Cardiovascular Medicine|October 3, 2003
EG-VEGF and Bv8. a novel family of tissue-selective mediators of angiogenesis, endothelial phenotype, and functionJennifer LeCouter, Napoleone FerraraPageof 22